Research article · 30 Jun 2026
Conference abstractPublished 2018
Serum zinc and copper levels and Cu:Zn ratio in chronic plaque psoriasis: a case-control study of 50 cases
Waves Wellness Clinic, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: Zinc and copper are important cofactors and modulators of many critical biological functions in different dermatological diseases including psoriasis as they are involved in a number of cellular metabolic activities. Objectives: To study the levels of serum zinc, serum copper as well as copper/zinc (Cu: Zn) ratio in psoriasis and the role of Cu: Zn ratio as a marker of severity of psoriasis. Methods: Fifty patients of the age group of 20-50 years having chronic plaque psoriasis were studied along with 50 ages and sex matched healthy controls. Patients with psoriasis area severity index (PASI) less than 10 were considered as mild psoriasis and PASI greater than 10 considered as moderate to severe psoriasis. Serum zinc and copper were studied using the colorimetric method and analyzed by a fully automated biochemistry analyzer. Results: Patients with moderate to severe psoriasis have higher (121.29±42.75) mean serum copper levels than controls (99.9±23.1, p=0.0049) but there is no significant difference in serum copper level between mild and moderate to severe psoriasis ( P=0.2265). Patients with moderate to severe psoriasis have lower mean serum zinc (66.38±24.33) than controls (82.4±15.9, p=0.0006) but there is no significant difference in serum zinc level between mild and moderate to severe psoriasis (P=0.1607). Also, patients with moderate to severe psoriasis have higher mean serum copper/zinc ratio (2.04±1.04) than those with mild psoriasis (1.54±0.71) and controls (1.2±0.3). Serum copper/zinc ratio correlates significantly with PASI and can be used as a marker for assessing the severity of the disease. Conclusion: This study suggests that serum copper/zinc ratio is the better marker for assessing the severity of psoriasis. Moreover, the therapeutic potential of these findings needs to be explored.
Subjects
DermatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Dermatology Research Journal.
Editorial · 30 Jun 2026
Advances in Clinical Dermatology: Emerging Research and Therapeutic Innovations
Editorial · 30 Jun 2026
Clinical Dermatology Research: Current Trends in Diagnosis, Management, and Patient Care
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Dermatology Research Journal
- SubjectDermatology
- BylineArticles whose byline prints “Ipsa Pandya”
